看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | Yes |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | No |
| Competitors Used |
|---|
| Novo Nordisk A/S |
| Almirall, S.A. |
| AstraZeneca PLC |
| GSK plc |
| Roche Holding AG |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| NOVO B | ALM | AZN | GS71 | RO | HLUN A | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 81% | 1% | 18% | 19% | 27% | 13% | ||
| Fiscal Year - 1 | 88% | -3% | 16% | 41% | 40% | 11% | ||
| Fiscal Year - 2 | 72% | 0% | 9% | 35% | 47% | 10% | ||
| Fiscal Year - 3 | 71% | -3% | 0% | 22% | 46% | 7% | ||
| Fiscal Year - 4 | 70% | 6% | 22% | 37% | 41% | 9% | ||
| Fiscal Year - 5 | 71% | 9% | 10% | 61% | 45% | 15% | ||
| Average | 75% | 2% | 12% | 36% | 41% | 11% | ||
| Median | 72% | 1% | 13% | 36% | 43% | 10% | ||
| Benchmarks | Ticker | |||||||
| Novo Nordisk A/S | CPSE:NOVOB | |||||||
| Almirall, S.A. | BME:ALM | |||||||
| AstraZeneca PLC | OM:AZN | |||||||
| GSK plc | DB:GS71 | |||||||
| Roche Holding AG | SWX:RO | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | NOVO B | ALM | AZN | GS71 | RO | HLUN A | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 290,403 | 991 | 54,073 | 31,376 | 62,395 | 22,004 | ||
| Fiscal Year | 290,403 | 991 | 54,073 | 31,376 | 62,395 | 22,004 | ||
| Fiscal Year - 1 | 232,261 | 899 | 45,811 | 30,328 | 60,441 | 19,912 | ||
| Fiscal Year - 2 | 176,954 | 879 | 44,351 | 29,324 | 65,814 | 18,246 | ||
| Fiscal Year - 3 | 140,800 | 837 | 37,417 | 24,696 | 65,850 | 16,299 | ||
| Fiscal Year - 4 | 126,946 | 814 | 26,617 | 24,354 | 60,343 | 17,672 | ||
| Fiscal Year - 5 | 122,021 | 911 | 24,384 | 33,754 | 63,751 | 17,036 | ||
| Net Income | ||||||||
| Latest Twelve Months | 100,988 | 10 | 7,035 | 2,575 | 8,277 | 3,143 | ||
| Fiscal Year | 100,988 | 10 | 7,035 | 2,575 | 8,277 | 3,143 | ||
| Fiscal Year - 1 | 83,683 | (38) | 5,955 | 4,928 | 11,498 | 2,290 | ||
| Fiscal Year - 2 | 55,525 | 4 | 3,288 | 4,461 | 12,421 | 1,916 | ||
| Fiscal Year - 3 | 47,757 | (41) | 112 | 3,316 | 13,930 | 1,318 | ||
| Fiscal Year - 4 | 42,138 | 74 | 3,196 | 4,873 | 14,295 | 1,581 | ||
| Fiscal Year - 5 | 38,951 | 106 | 1,335 | 4,645 | 13,497 | 2,313 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 314,486 | 2,375 | 101,119 | 59,005 | 90,468 | 37,407 | ||
| Latest Fiscal Quarter | 465,795 | 2,397 | 104,035 | 59,463 | 101,801 | 56,976 | ||
| Fiscal Year | 465,795 | 2,397 | 104,035 | 59,463 | 101,801 | 56,976 | ||
| Fiscal Year - 1 | 314,486 | 2,375 | 101,119 | 59,005 | 90,468 | 37,407 | ||
| Fiscal Year - 2 | 241,257 | 2,148 | 96,483 | 60,146 | 88,151 | 37,452 | ||
| Fiscal Year - 3 | 194,508 | 2,142 | 105,363 | 79,103 | 92,317 | 34,653 | ||
| Fiscal Year - 4 | 144,922 | 2,291 | 66,729 | 80,431 | 86,138 | 36,029 | ||
| Fiscal Year - 5 | 125,612 | 2,440 | 61,377 | 79,692 | 83,091 | 38,133 | ||
| Fiscal Year - 6 | 110,769 | 2,390 | 60,651 | 58,066 | 78,517 | 23,011 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 106,561 | 1,463 | 39,143 | 13,347 | 29,315 | 22,045 | ||
| Latest Fiscal Quarter | 143,486 | 1,488 | 40,786 | 13,671 | 31,767 | 25,010 | ||
| Fiscal Year | 143,486 | 1,488 | 40,786 | 13,671 | 31,767 | 25,010 | ||
| Fiscal Year - 1 | 106,561 | 1,463 | 39,143 | 13,347 | 29,315 | 22,045 | ||
| Fiscal Year - 2 | 83,486 | 1,319 | 37,037 | 10,598 | 27,992 | 20,779 | ||
| Fiscal Year - 3 | 70,746 | 1,286 | 39,268 | 15,055 | 24,489 | 18,279 | ||
| Fiscal Year - 4 | 63,325 | 1,303 | 15,622 | 14,587 | 36,341 | 16,973 | ||
| Fiscal Year - 5 | 57,593 | 1,280 | 13,127 | 11,405 | 32,747 | 16,782 | ||
| Fiscal Year - 6 | 51,839 | 1,192 | 12,468 | 3,781 | 27,622 | 14,251 | ||